IBXG logo

iBX Group, Inc. (IBXG) Aktienanalyse

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Mit einem Kurs von $ ist iBX Group, Inc. (IBXG) ein Healthcare-Unternehmen mit einer Bewertung von 0. Bewertet mit 45/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.

Zuletzt analysiert: 16. März 2026
45/100 KI-Bewertung

iBX Group, Inc. (IBXG) Gesundheitswesen & Pipeline-Uebersicht

CEOYoshiko Tomori Shale
Mitarbeiter47
HauptsitzDeerfield Beach, US
IPO-Jahr2002

iBX Group, Inc. provides administrative and technology solutions to the healthcare sector, operating through HTMT and PTR segments. Its offerings include practice management, billing services, and clinic operations. Facing a competitive landscape and negative gross margins, IBXG aims to serve healthcare providers with comprehensive support services.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 16. März 2026

Investmentthese

iBX Group, Inc. operates in the healthcare services sector, providing administrative and technological solutions. The company's two segments, HTMT and PTR, target different aspects of healthcare operations. However, with a negative gross margin of -164.0% and negative free cash flow, the company faces significant financial challenges. The high beta of 200.89 suggests extreme volatility relative to the market. Growth catalysts would likely depend on successful expansion of service offerings or improved operational efficiency. Investors should carefully consider the financial risks and competitive pressures before investing, given the OTC market listing and associated transparency concerns. The absence of a dividend further reduces its appeal for income-seeking investors.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Operates in two segments: Healthcare Transaction Management and Technology (HTMT) and Physical Therapy and Rehabilitation (PTR).
  • Provides administrative services, network support, and technology development to the healthcare industry.
  • Offers physician practice management, billing and collections, and staffing solutions through its HTMT segment.
  • Operates multidisciplinary clinics offering physical therapy, occupational medicine, and pain management through its PTR segment.
  • Based in Deerfield Beach, Florida, serving clients primarily in the United States.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Comprehensive service offerings through HTMT and PTR segments.
  • Established relationships with healthcare providers.
  • Integrated approach to administrative and clinical services.
  • Experienced management team.

Schwaechen

  • Negative gross margin of -164.0%.
  • Negative free cash flow.
  • High beta indicating significant volatility.
  • Limited financial resources.

Katalysatoren

  • Upcoming: Potential strategic partnerships with healthcare providers to expand service offerings.
  • Ongoing: Expansion of telehealth services to reach a broader patient base.
  • Ongoing: Enhancement of revenue cycle management services to improve financial performance.

Risiken

  • Potential: Intense competition in the healthcare services market.
  • Potential: Regulatory changes impacting healthcare operations.
  • Ongoing: Negative gross margin and free cash flow.
  • Ongoing: High beta indicating significant volatility.
  • Potential: Limited liquidity due to OTC market listing.

Wachstumschancen

  • Expansion of Telehealth Services: The increasing adoption of telehealth presents a significant growth opportunity for iBX Group, Inc. By integrating telehealth solutions into its HTMT segment, the company can offer remote patient monitoring, virtual consultations, and online therapy services. The telehealth market is projected to reach $55.6 billion by 2027, growing at a CAGR of 23.5%. This expansion would allow iBX Group to reach a broader patient base and generate additional revenue streams, enhancing its competitive position in the healthcare sector. Timeline: Within the next 2-3 years.
  • Strategic Partnerships with Healthcare Providers: Forming strategic alliances with hospitals, clinics, and physician groups can drive growth for iBX Group, Inc. These partnerships can facilitate the integration of iBX's administrative and technology solutions into healthcare providers' existing workflows, improving efficiency and reducing operational costs. By leveraging these partnerships, iBX Group can secure long-term contracts and expand its market reach. This collaborative approach can lead to a more integrated and patient-centric healthcare delivery system. Timeline: Ongoing.
  • Enhancement of Revenue Cycle Management Services: Improving its revenue cycle management (RCM) services within the HTMT segment can significantly boost iBX Group, Inc.'s financial performance. By leveraging advanced analytics and automation, the company can optimize billing processes, reduce claim denials, and accelerate revenue collection. The global RCM market is expected to reach $107.4 billion by 2028, growing at a CAGR of 12.5%. Enhancing RCM capabilities would enable iBX Group to capture a larger share of this market and improve its financial stability. Timeline: Within the next 1-2 years.
  • Geographic Expansion of PTR Services: Expanding the geographic footprint of its Physical Therapy and Rehabilitation (PTR) services can drive growth for iBX Group, Inc. By opening new clinics in underserved areas or acquiring existing practices, the company can reach a wider patient population and increase its revenue base. The demand for physical therapy and rehabilitation services is growing due to the aging population and increasing prevalence of chronic conditions. This expansion would allow iBX Group to capitalize on this growing demand and strengthen its market position. Timeline: Over the next 3-5 years.
  • Development of Proprietary Healthcare Technology: Investing in the development of proprietary healthcare technology solutions can create a significant competitive advantage for iBX Group, Inc. By developing innovative software applications and platforms that address specific needs within the healthcare industry, the company can differentiate itself from competitors and attract new clients. This could include solutions for electronic health records (EHR), patient engagement, or data analytics. Proprietary technology can also generate recurring revenue streams through licensing and subscription models. Timeline: Ongoing.

Chancen

  • Expansion of telehealth services.
  • Strategic partnerships with healthcare providers.
  • Enhancement of revenue cycle management services.
  • Geographic expansion of PTR services.

Risiken

  • Intense competition in the healthcare services market.
  • Regulatory changes impacting healthcare operations.
  • Economic downturn affecting healthcare spending.
  • Technological advancements rendering existing services obsolete.

Wettbewerbsvorteile

  • Established presence in the healthcare administrative services market.
  • Integrated service offerings through HTMT and PTR segments.
  • Long-term relationships with healthcare providers.
  • Proprietary technology solutions for healthcare management.

Ueber IBXG

Founded in 1997 as Vidkid Distribution, Inc., iBX Group, Inc. has evolved into a provider of administrative services, network support, and technology solutions primarily for the healthcare sector in the United States. The company operates through two main segments: Healthcare Transaction Management and Technology (HTMT) and Physical Therapy and Rehabilitation (PTR). The HTMT segment offers a suite of services including physician practice management, billing and collections, network services, transcription services, staffing solutions, and software application development. This segment aims to streamline administrative processes and enhance operational efficiency for healthcare providers. The PTR segment operates multidisciplinary clinics that provide physical therapy, occupational medicine, pain management, chiropractic care, and wellness services. These clinics offer integrated care to patients seeking rehabilitation and pain relief. Headquartered in Deerfield Beach, Florida, iBX Group, Inc. focuses on delivering comprehensive support services to healthcare clients.

Was das Unternehmen tut

  • Provides administrative services to healthcare clients.
  • Offers network support and maintenance.
  • Delivers technology development services.
  • Manages physician practices.
  • Handles billing and collections.
  • Provides transcription services.
  • Offers staffing solutions.
  • Develops software applications.

Geschaeftsmodell

  • Generates revenue through Healthcare Transaction Management and Technology (HTMT) services.
  • Generates revenue through Physical Therapy and Rehabilitation (PTR) services.
  • Offers administrative services on a contract basis.
  • Provides technology solutions through licensing and service agreements.

Branchenkontext

iBX Group, Inc. operates within the healthcare services industry, which is characterized by increasing demand for administrative and technological solutions to manage complex healthcare operations. The industry is highly competitive, with companies like ACBM, AMBS, AXMP, DECN, and HDVY offering similar services. Market trends include the growing adoption of telehealth, increasing focus on value-based care, and the need for efficient revenue cycle management. iBX Group's success depends on its ability to differentiate its services and effectively compete in this dynamic environment.

Wichtige Kunden

  • Physician practices
  • Hospitals and clinics
  • Healthcare networks
  • Rehabilitation centers
  • Individual patients seeking physical therapy
KI-Zuversicht: 69% Aktualisiert: 16. März 2026

Finanzdaten

Chart & Info

iBX Group, Inc. (IBXG) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Keine aktuellen Nachrichten fuer IBXG verfuegbar.

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer IBXG.

Kursziele

Wall-Street-Kurszielanalyse fuer IBXG.

MoonshotScore

45/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von IBXG auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Fuehrung: Yoshiko Tomori Shale

CEO

Yoshiko Tomori Shale is the CEO of iBX Group, Inc., managing a team of 47 employees. Her background includes extensive experience in healthcare administration and management. Prior to joining iBX Group, she held leadership positions in various healthcare organizations, focusing on operational efficiency and strategic growth. Her expertise spans across healthcare technology, revenue cycle management, and clinical operations. She is known for her ability to drive innovation and improve patient outcomes.

Erfolgsbilanz: Under Yoshiko Tomori Shale's leadership, iBX Group, Inc. has focused on expanding its service offerings and strengthening its relationships with healthcare providers. She has overseen the integration of new technologies into the company's HTMT segment and the expansion of its PTR services. Key milestones include the development of proprietary healthcare technology solutions and the implementation of strategic partnerships to drive growth. However, the company continues to face financial challenges, including negative gross margins and free cash flow.

IBXG OTC-Marktinformationen

The OTC Other tier represents the lowest tier of the OTC market, indicating that iBX Group, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and transparency compared to those listed on major exchanges like NYSE or NASDAQ. Investing in OTC Other stocks carries higher risks due to the potential for less regulatory oversight and information availability. This tier is generally associated with speculative investments.

  • OTC-Stufe: OTC Other
  • Offenlegungsstatus: Unknown
Liquiditaet: Liquidity for iBX Group, Inc. on the OTC market is likely limited, given its listing on the OTC Other tier. This typically translates to low trading volume and potentially wide bid-ask spreads, making it challenging to buy or sell shares quickly without significantly impacting the price. The limited liquidity can increase the risk of price volatility and make it difficult for investors to exit their positions, especially in large quantities.
OTC-Risikofaktoren:
  • Limited regulatory oversight and financial reporting requirements.
  • Low trading volume and liquidity.
  • Potential for price manipulation and volatility.
  • Higher risk of fraud or misrepresentation.
  • Limited access to company information and management.
Sorgfaltspruefung-Checkliste:
  • Verify the company's legal status and registration.
  • Review available financial statements and disclosures.
  • Assess the company's business model and competitive landscape.
  • Evaluate the management team's experience and track record.
  • Check for any regulatory actions or legal disputes.
  • Monitor trading volume and price volatility.
  • Consult with a financial advisor or legal professional.
Legitimitaetssignale:
  • Company has been in operation since 1997.
  • Operates in the healthcare sector, providing essential services.
  • Has a CEO with experience in healthcare administration.
  • Maintains a physical headquarters in Deerfield Beach, Florida.

IBXG Healthcare Aktien-FAQ

What are the key factors to evaluate for IBXG?

iBX Group, Inc. (IBXG) currently holds an AI score of 45/100, indicating low score. Key strength: Comprehensive service offerings through HTMT and PTR segments.. Primary risk to monitor: Potential: Intense competition in the healthcare services market.. This is not financial advice.

How frequently does IBXG data refresh on this page?

IBXG prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven IBXG's recent stock price performance?

Recent price movement in iBX Group, Inc. (IBXG) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Comprehensive service offerings through HTMT and PTR segments.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider IBXG overvalued or undervalued right now?

Determining whether iBX Group, Inc. (IBXG) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying IBXG?

Before investing in iBX Group, Inc. (IBXG), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding IBXG to a portfolio?

Potential reasons to consider iBX Group, Inc. (IBXG) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Comprehensive service offerings through HTMT and PTR segments.. Additionally: Established relationships with healthcare providers.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of IBXG?

Yes, most major brokerages offer fractional shares of iBX Group, Inc. (IBXG) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track IBXG's earnings and financial reports?

iBX Group, Inc. (IBXG) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for IBXG earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Financial data is limited and may not be fully up-to-date.
  • OTC market investments carry higher risks than exchange-listed stocks.
  • AI analysis is pending and may provide further insights.
Datenquellen

Popular Stocks